Ignyta (RXDX) Rating Lowered to Neutral at Cantor Fitzgerald

Jose Verdugo
Diciembre 31, 2017

Shares of Ignyta (RXDX) opened at $26.70 on Wednesday. 35 funds opened positions while 38 raised stakes.

Ignyta, Inc. (NASDAQ:RXDX) gross margin percentage stands at 0% while its operating margin for the past trailing twelve month is 0 percent and its overall profit margin (ttm) is 0 Percent. Trading volume for Ignyta, Inc. was 6.55 Million in its previous trading session. Knott David M owns 67,700 shares. Ignyta, Inc.is based in San Diego, California. (NASDAQ:RXDX) for 900,000 shares. Metropolitan Life Insur Communications stated it has 0% of its portfolio in Ignyta, Inc. (NASDAQ:RXDX). Moreover, State Of Wisconsin Inv Board has 0% invested in Ignyta, Inc. Aqr Cap Mgmt Ltd Liability Com invested 0% in Ignyta, Inc. (NASDAQ:RXDX) for 53,979 shares. State Street holds 0% of its portfolio in Ignyta, Inc. (NASDAQ:RXDX). American Century Cos reported 0% stake. Tang Capital Mgmt Ltd Llc invested in 17.96% or 4.76 million shares. 133,757 were reported by D E Shaw And Com Inc. (NASDAQ:RXDX). Millennium Limited Liability Corp owns 248,770 shares for 0% of their portfolio. Moreover, Spark Lc has 0.04% invested in Ignyta, Inc. Royal Financial Bank Of Canada stated it has 0% of its portfolio in Ignyta, Inc. (NASDAQ:RXDX) for 160,000 shares. (NASDAQ:RXDX). Voya Investment Management Llc has invested 0% in Ignyta, Inc. About 2.71M shares traded or 25.67% up from the average. The biopharmaceutical company reported ($0.51) earnings per share for the quarter, beating the consensus estimate of ($0.54) by $0.03. sell-side analysts predict that Ignyta will post -2.27 EPS for the current fiscal year. Cormorant Asset Management Llc who had been investing in Ignyta Inc for a number of months, seems to be bullish on the $1.77B market cap company.

The stock increased 0.19% or $0.05 during the last trading session, reaching $26.75. About 736,245 shares traded. Ignyta, Inc. (NASDAQ:RXDX) has risen 14.24% since December 30, 2016 and is uptrending. It has underperformed by 2.46% the S&P500.

Cormorant Asset Management Llc, which manages about $841.40 million and $566.36 million US Long portfolio, decreased its stake in Portola Pharmaceuticals Inc (NASDAQ:PTLA) by 400,000 shares to 500,000 shares, valued at $27.02M in 2017Q3, according to the filing. It also reduced its holding in Gemphire Therapeutics Inc by 152,798 shares in the quarter, leaving it with 800,000 shares, and cut its stake in Bluebird Bio Inc (NASDAQ:BLUE).

More news: Forte's career may be over after being placed on IR

Insider data can help an investor form an outlook on a stock, but it's important to supplement this data with other information such as technical indicators to form a more complete view. For: Dec 26 Filed by: McCarthy William R", Fool.com published: "Why Ignyta, Inc. Acquisition" with publication date: "December 22, 2017. Polar Capital Ltd Liability Partnership holds 0.05% in Ignyta, Inc. (NASDAQ:RXDX) news were published by: Wsj.com which released: "Roche Bolsters Cancer Portfolio With $1.7 Billion Ignyta Deal" on December 22, 2017, also Prnewswire.com published article titled: "WeissLaw LLP Investigates Ignyta Inc". They issued a buy rating for the company. Therefore 70% are positive.

Among 18 analysts covering CIGNA (NYSE:CI), 15 have Buy rating, 0 Sell and 3 Hold. Credit Suisse initiated Ignyta, Inc. (NASDAQ:RXDX) has "Buy" rating given on Monday, July 10 by Cantor Fitzgerald. (NASDAQ:RXDX) rating on Friday, October 23. The firm has "Hold" rating given on Tuesday, December 26 by SunTrust. Credit Suisse maintained Ignyta, Inc.

New York: In a research note revealed to clients on Friday morning, Jefferies reiterated their Buy rating on Ignyta Inc (NASDAQ:RXDX) shares. As per Thursday, June 23, the company rating was initiated by JP Morgan. Cantor Fitzgerald initiated the stock with "Buy" rating in Tuesday, November 10 report. Finally, Jefferies Group downgraded Ignyta from a buy rating to a hold rating and set a $27.00 price target for the company.in a research report on Friday, December 22nd. The firm has "Buy" rating given on Tuesday, November 21 by SunTrust.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Otros informes por

Discuta este artículo

SIGUE NUESTRO PERIÓDICO